Brief: Tarsus Pharmaceuticals Says Public Offering Of 5.71 Mln Common Shares Priced At $17.50 Per Share
02/08/2023 03:32
Aug 1 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS ANNOUNCES PRICING OF $100.0 MILLION UNDERWRITTEN
PUBLIC
OFFERING OF COMMON STOCK
* TARSUS PHARMACEUTICALS INC SAYS PUBLIC OFFERING OF 5.71
MILLION
COMMON SHARES PRICED AT $17.50PER SHARE
Source text for Eikon: ID:nGNXM93v4
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)